These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8169924)

  • 1. Vulvar lichen sclerosus. Immunohistologic evaluation before and after therapy.
    Carli P; Bracco G; Taddei G; Sonni L; De Marco A; Maestrini G; Cattaneo A
    J Reprod Med; 1994 Feb; 39(2):110-4. PubMed ID: 8169924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus.
    Carli P; Cattaneo A; Pimpinelli N; Cozza A; Bracco G; Giannotti B
    Dermatologica; 1991; 182(1):18-22. PubMed ID: 2013351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin.
    Farrell AM; Marren P; Dean D; Wojnarowska F
    Br J Dermatol; 1999 Jun; 140(6):1087-92. PubMed ID: 10354075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation.
    Bracco GL; Carli P; Sonni L; Maestrini G; De Marco A; Taddei GL; Cattaneo A
    J Reprod Med; 1993 Jan; 38(1):37-40. PubMed ID: 8441129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone pellet implant therapy for lichen sclerosus.
    Wright AJ
    Mo Med; 1993 Nov; 90(11):711-3. PubMed ID: 8277936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine alterations in lichen sclerosus: an immunohistochemical study.
    Farrell AM; Dean D; Millard PR; Charnock FM; Wojnarowska F
    Br J Dermatol; 2006 Nov; 155(5):931-40. PubMed ID: 17034521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases.
    Carlson JA; Lamb P; Malfetano J; Ambros RA; Mihm MC
    Mod Pathol; 1998 Sep; 11(9):844-54. PubMed ID: 9758364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study.
    Carli P; Moretti S; Spallanzani A; Berti E; Cattaneo A
    J Reprod Med; 1997 Mar; 42(3):161-5. PubMed ID: 9109084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region].
    Cattaneo A; De Marco A; Sonni L; Bracco GL; Carli P; Taddei GL
    Minerva Ginecol; 1992 Nov; 44(11):567-71. PubMed ID: 1480305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream.
    Dalziel KL; Wojnarowska F
    J Reprod Med; 1993 Jan; 38(1):25-7. PubMed ID: 8441126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous--implications for pathogenesis.
    Carlson JA; Grabowski R; Chichester P; Paunovich E; Malfetano J
    Am J Dermatopathol; 2000 Feb; 22(1):7-16. PubMed ID: 10698209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parapsoriasis en plaques. Characterization of the cellular infiltrate using monoclonal antibodies].
    Büchner SA
    Z Hautkr; 1988 May; 63(5):423-4, 427-9. PubMed ID: 3043952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
    Goldstein AT; Marinoff SC; Christopher K
    J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate.
    Cattaneo A; Carli P; De Marco A; Sonni L; Bracco G; De Magnis A; Taddei GL
    J Reprod Med; 1996 Feb; 41(2):99-102. PubMed ID: 8656422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cells in vulvar lichen sclerosus and vulvar squamous cell carcinoma.
    Rotsztejn H; Trznadel-Budźko E; Jesionek-Kupnicka D
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):363-6. PubMed ID: 17031466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug treatment in vulvar lichen sclerosus].
    Zarcone R; Vicinanza G; Bellini P; Cardone A
    Minerva Ginecol; 1996 Oct; 48(10):441-4. PubMed ID: 9005369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus.
    Bornstein J; Heifetz S; Kellner Y; Stolar Z; Abramovici H
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):80-4. PubMed ID: 9465808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
    Meunier L; Gonzalez-Ramos A; Cooper KD
    J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lichen striatus versus linear lichen planus: a comparison of clinicopathological features, immunoprofile of infiltrated cells, and epidermal proliferation and differentiation.
    Zhou Y; Yu ZZ; Peng J; Yang PP; Li SJ; Fan YM
    Int J Dermatol; 2016 Apr; 55(4):e204-10. PubMed ID: 26785261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia.
    Ayhan A; Guven ES; Guven S; Sakinci M; Dogan NU; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(6):715-9. PubMed ID: 17520405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.